Trials / Recruiting
RecruitingNCT04938804
Non-risk Based Lang Cancer Screening With a One-off LDCT
Non-risk Based Lung Cancer Screening With One-time Low-dose Computed Tomography: a Prospective Cohort Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11,000 (estimated)
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
- Sex
- All
- Age
- 40 Years – 74 Years
- Healthy volunteers
- Accepted
Summary
Guangzhou Lung-Care Project is a single-arm, prospective cohort study using one-time low-dose computed tomography for the early detection of LC, recruiting residents aged 40-74 years from four communities in Guangzhou between 2015 and 2021.The primary outcome was LC detection rate in eligible participants without restrictions based on high-risk factors and the proportion of stage I LC cases, and to investigate the various factors associated with the development of LC.
Detailed description
Guangzhou Lung-Care Project is a single-arm, prospective cohort study using one-time low-dose computed tomography for the early detection of LC, recruiting residents aged 40-74 years from four communities in Guangzhou between 2015 and 2021. Follow-up for post-screening management and survival was recorded. The primary outcome was LC detection rate in eligible participants without restrictions based on high-risk factors and the proportion of stage I LC cases, and to investigate the various factors associated with the development of LC. Additionally, we compared the detection rates of LC and the proportion of stage I LC cases between "high-risk" and "non-high-risk" groups according to the National Comprehensive Cancer Network (NCCN) guidelines and Chinese guideline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low-dose computed tomography | The Low-dose computed tomography is conducted according to the guideline suggested by American College of Radiology. |
Timeline
- Start date
- 2015-12-12
- Primary completion
- 2025-12-01
- Completion
- 2026-12-01
- First posted
- 2021-06-24
- Last updated
- 2024-01-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04938804. Inclusion in this directory is not an endorsement.